122 related articles for article (PubMed ID: 10319407)
1. Expression of two dead box genes (DDX1 and DDX6) is independent of that of MYCN in human neuroblastoma cell lines.
Akiyama K; Akao Y; Yokoyama M; Nakagawa Y; Noguchi T; Yagi K; Nishi Y
Biochem Mol Biol Int; 1999 Apr; 47(4):563-8. PubMed ID: 10319407
[TBL] [Abstract][Full Text] [Related]
2. Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma.
Squire JA; Thorner PS; Weitzman S; Maggi JD; Dirks P; Doyle J; Hale M; Godbout R
Oncogene; 1995 Apr; 10(7):1417-22. PubMed ID: 7731693
[TBL] [Abstract][Full Text] [Related]
3. The DDX1 gene maps within 400 kbp 5' to MYCN and is frequently coamplified in human neuroblastoma.
Amler LC; Schürmann J; Schwab M
Genes Chromosomes Cancer; 1996 Feb; 15(2):134-7. PubMed ID: 8834178
[TBL] [Abstract][Full Text] [Related]
4. Co-amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma.
Manohar CF; Salwen HR; Brodeur GM; Cohn SL
Genes Chromosomes Cancer; 1995 Nov; 14(3):196-203. PubMed ID: 8589036
[TBL] [Abstract][Full Text] [Related]
5. Amplification of a DEAD box gene (DDX1) with the MYCN gene in neuroblastomas as a result of cosegregation of sequences flanking the MYCN locus.
Noguchi T; Akiyama K; Yokoyama M; Kanda N; Matsunaga T; Nishi Y
Genes Chromosomes Cancer; 1996 Feb; 15(2):129-33. PubMed ID: 8834177
[TBL] [Abstract][Full Text] [Related]
6. Physical mapping of the DDX1 gene to 340 kb 5' of MYCN.
Kuroda H; White PS; Sulman EP; Manohar CF; Reiter JL; Cohn SL; Brodeur GM
Oncogene; 1996 Oct; 13(7):1561-5. PubMed ID: 8875996
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of a DEAD box protein (DDX1) in neuroblastoma and retinoblastoma cell lines.
Godbout R; Packer M; Bie W
J Biol Chem; 1998 Aug; 273(33):21161-8. PubMed ID: 9694872
[TBL] [Abstract][Full Text] [Related]
8. Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. United Kingdom Children's Cancer Study Group.
George RE; Kenyon RM; McGuckin AG; Malcolm AJ; Pearson AD; Lunec J
Oncogene; 1996 Apr; 12(7):1583-7. PubMed ID: 8622876
[TBL] [Abstract][Full Text] [Related]
9. Coamplification of DDX1 correlates with an improved survival probability in children with MYCN-amplified human neuroblastoma.
Weber A; Imisch P; Bergmann E; Christiansen H
J Clin Oncol; 2004 Jul; 22(13):2681-90. PubMed ID: 15226335
[TBL] [Abstract][Full Text] [Related]
10. Relationship of DDX1 and NAG gene amplification/overexpression to the prognosis of patients with MYCN-amplified neuroblastoma.
Kaneko S; Ohira M; Nakamura Y; Isogai E; Nakagawara A; Kaneko M
J Cancer Res Clin Oncol; 2007 Mar; 133(3):185-92. PubMed ID: 17028906
[TBL] [Abstract][Full Text] [Related]
11. Concomitant DDX1 and MYCN gain in neuroblastoma.
Defferrari R; Tonini GP; Conte M; Papio F; Sementa AR; Valent A; Schena F; Perri P; Mazzocco K
Cancer Lett; 2007 Oct; 256(1):56-63. PubMed ID: 17611020
[TBL] [Abstract][Full Text] [Related]
12. Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay.
De Preter K; Speleman F; Combaret V; Lunec J; Laureys G; Eussen BH; Francotte N; Board J; Pearson AD; De Paepe A; Van Roy N; Vandesompele J
Mod Pathol; 2002 Feb; 15(2):159-66. PubMed ID: 11850545
[TBL] [Abstract][Full Text] [Related]
13. No evidence for correlation of DDX1 gene amplification with improved survival probability in patients with MYCN-amplified neuroblastomas.
De Preter K; Speleman F; Combaret V; Lunec J; Board J; Pearson A; De Paepe A; Van Roy N; Laureys G; Vandesompele J
J Clin Oncol; 2005 May; 23(13):3167-8; author reply 3168-70. PubMed ID: 15860893
[No Abstract] [Full Text] [Related]
14. Amplification of Mycn, Ddx1, Rrm2, and Odc1 in rat uterine endometrial carcinomas.
Karlsson A ; Helou K; Walentinsson A; Hedrich HJ; Szpirer C; Levan G
Genes Chromosomes Cancer; 2001 Aug; 31(4):345-56. PubMed ID: 11433525
[TBL] [Abstract][Full Text] [Related]
15. Genes co-amplified with MYCN in neuroblastoma: silent passengers or co-determinants of phenotype?
Scott D; Elsden J; Pearson A; Lunec J
Cancer Lett; 2003 Jul; 197(1-2):81-6. PubMed ID: 12880964
[TBL] [Abstract][Full Text] [Related]
16. Co-overexpression of DEAD box protein rck/p54 and c-myc protein in human colorectal adenomas and the relevance of their expression in cultured cell lines.
Hashimoto K; Nakagawa Y; Morikawa H; Niki M; Egashira Y; Hirata I; Katsu K; Akao Y
Carcinogenesis; 2001 Dec; 22(12):1965-70. PubMed ID: 11751426
[TBL] [Abstract][Full Text] [Related]
17. Oncogene RNA helicase DDX6 promotes the process of c-Myc expression in gastric cancer cells.
Taniguchi K; Iwatsuki A; Sugito N; Shinohara H; Kuranaga Y; Oshikawa Y; Tajirika T; Futamura M; Yoshida K; Uchiyama K; Akao Y
Mol Carcinog; 2018 May; 57(5):579-589. PubMed ID: 29314290
[TBL] [Abstract][Full Text] [Related]
18. Analysis of candidate gene co-amplification with MYCN in neuroblastoma.
George RE; Kenyon R; McGuckin AG; Kohl N; Kogner P; Christiansen H; Pearson AD; Lunec J
Eur J Cancer; 1997 Oct; 33(12):2037-42. PubMed ID: 9516849
[TBL] [Abstract][Full Text] [Related]
19. Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas.
Westermann F; Muth D; Benner A; Bauer T; Henrich KO; Oberthuer A; Brors B; Beissbarth T; Vandesompele J; Pattyn F; Hero B; König R; Fischer M; Schwab M
Genome Biol; 2008 Oct; 9(10):R150. PubMed ID: 18851746
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of MYCN, DDX1, TrkA, and TrkC gene transcripts expression in neuroblastoma.
de Souza DR; Sanabani SS; de Souza AC; Filho Odone V; Epelman S; Bendit I
Pediatr Blood Cancer; 2011 May; 56(5):749-56. PubMed ID: 21154590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
